Ameloblastoma

Overview

Ameloblastoma is a rare tumor that typically develops in the jawbone. This tumor originates from cells that form tooth enamel (ameloblasts). Ameloblastoma is usually benign but exhibits aggressive growth characteristics and, if left untreated, can damage surrounding tissues and bones.

Ameloblastoma most commonly occurs in the lower jaw (mandible), particularly in the molar region and near the jaw joint. Less frequently, it can develop in the upper jaw (maxilla). The tumor grows slowly and may go unnoticed for years. It is generally diagnosed between ages 20-40 but can occur at any age.

Ameloblastoma is not cancerous, meaning it does not spread to other parts of the body (metastasize). However, it is locally invasive; it infiltrates bone tissue, destroys surrounding structures, and has a high risk of recurrence after treatment. Therefore, aggressive treatment is required.

Ameloblastoma has several subtypes.

• Conventional (solid/multicystic) ameloblastoma is the most common and most aggressive type.
• Unicystic ameloblastoma presents as a single cyst and is generally less aggressive.
• Peripheral ameloblastoma is a very rare type that develops in the gum tissue with minimal or no bone involvement.
• Desmoplastic ameloblastoma is a rarer variant that grows more slowly.

Untreated ameloblastoma can deform the jaw shape, cause tooth loss, affect chewing and speech functions. In very advanced cases, it can obstruct the airway or lead to infections. Early diagnosis and appropriate surgical treatment prevent these complications and reduce the risk of recurrence.

Treatment of ameloblastoma is generally surgical and involves complete removal of the tumor. The surgical approach varies according to the tumor's type, size, and location. Radiotherapy and chemotherapy are generally not effective. Long-term follow-up after treatment is important because recurrence can occur even years later.

Symptoms of Ameloblastoma

Ameloblastoma generally does not cause symptoms in early stages. As the tumor grows, symptoms appear. The most common symptoms are swelling and deformity of the jaw.

• Painless swelling in the jaw. The most common initial symptom of ameloblastoma is a slowly growing, usually painless swelling in the jaw. Swelling is more common in the lower jaw. It may not be noticed initially but grows over time and can cause facial asymmetry. The swelling may feel hard and bony. Sometimes noticing that one side of the face is swollen is the first sign.
• Jaw pain or tenderness. As the tumor grows and presses on surrounding tissues, mild pain or tenderness may develop. Pain is generally not severe but can be constant or intermittent. Discomfort may increase during chewing. Pain may intensify if infection develops.
• Loose or shifting teeth. Ameloblastoma affects tooth roots and can cause teeth to shift from their position. Teeth may become loose, misaligned, or fall out. A dentist may notice abnormal tooth movement during routine examination. In people wearing dentures, the denture may become ill-fitting.
• Difficulty chewing. If the tumor is near the jaw joint or large, moving the jaw can become difficult. There may be pain or limited jaw movement during chewing. Difficulty in fully opening the mouth (trismus) may develop.
• Facial deformity. Advanced ameloblastoma can significantly change the shape of the jaw and cause facial asymmetry. A protrusion in one cheek or distortion of the jaw line may be visible. This condition leads to aesthetic concerns and psychological stress.
• Numbness in the lip or chin. If the tumor presses on the inferior alveolar nerve, numbness, tingling, or loss of sensation in the lip, chin, or teeth may occur. This is a sign that the tumor is affecting nerve structures.
• Nasal congestion or breathing difficulty. If ameloblastoma in the upper jaw extends into the nasal cavity or sinuses, nasal congestion, breathing difficulty, or facial pain may occur. Sometimes swelling around the eye or double vision may be seen (in very advanced cases).
• Dental infection or abscess. If ameloblastoma destroys tooth roots or disrupts oral hygiene, recurrent dental infections, abscess formation, or gum swelling may develop. Bad breath and unpleasant taste in the mouth may also accompany.

When to See a Doctor

You should definitely see a dentist or oral surgeon in the following situations:

If you notice swelling or a protrusion in your jaw, especially if it has been growing for several weeks or months, evaluation should be done. Even if painless, it should not be ignored.

If your teeth become loose, shift, or you experience unexplained tooth loss, there may be an underlying problem. Your dentist should perform X-rays and examination.

If you experience difficulty chewing, speaking, or opening your mouth, this may indicate a jaw joint or bone problem. Early evaluation is important.

If you notice facial asymmetry, deformation, or a new protrusion, immediate specialist evaluation is needed. Because ameloblastoma grows slowly, early detection increases treatment success.

If you feel numbness in your lip, chin, or teeth, there may be nerve involvement and urgent evaluation is required.

Causes and Risk Factors of Ameloblastoma

The exact cause of ameloblastoma is unknown. However, some factors are thought to be associated with increased risk.

• Cell mutations during tooth development. Ameloblastoma originates from ameloblast cells that form tooth enamel. Genetic mutations in these cells during tooth development can lead to tumor formation. Mutations in BRAF and SMO genes have been associated with ameloblastoma. However, why these mutations occur is not fully understood.
• Impacted teeth. Impacted wisdom teeth (third molars) may increase the risk of developing ameloblastoma. The tumor often develops around the impacted tooth or from an associated follicular cyst. However, most impacted teeth do not lead to ameloblastoma.
• Dental cysts. Dental cysts such as dentigerous cyst (follicular cyst) or odontogenic keratocyst can sometimes transform into ameloblastoma. This is a rare occurrence but follow-up of chronic dental cysts is important.
• Trauma or infection. Whether jaw trauma or chronic dental infections increase ameloblastoma risk is unclear. Some experts believe these factors may be triggers, but evidence is limited.
• Age. Ameloblastoma is most commonly diagnosed between ages 20-40. However, it can also occur in children and the elderly. Unicystic ameloblastoma is more common at younger ages (10-30 years).
• Gender. Some studies suggest ameloblastoma is slightly more common in males, but the gender difference is not pronounced.
• Race and geography. Ameloblastoma is more common in some geographic regions and ethnic groups. Prevalence may be higher in African and Asian countries. It is rarer in Western countries.
• Genetic syndromes. In very rare cases, ameloblastoma may be associated with genetic syndromes such as basal cell nevus syndrome (Gorlin syndrome). However, most ameloblastomas are sporadic (occur randomly) and not hereditary.

Complications of Ameloblastoma

Untreated or late-diagnosed ameloblastoma can lead to serious complications. Aggressive growth of the tumor damages surrounding structures.

• Jaw bone deformation. Ameloblastoma expands and deforms the jawbone. This causes facial asymmetry, aesthetic problems, and psychological stress. In advanced cases, the jawbone becomes so thin that there is a risk of pathological fracture (spontaneous breaking).
• Tooth loss. The tumor destroys tooth roots and leads to tooth loss. Multiple teeth may be affected. Tooth loss negatively affects chewing function, speech, and quality of life. Denture construction may also become difficult due to the tumor.
• Difficulty chewing and speaking. Disruption of jaw bone structure affects chewing function. Movement of the jaw joint may be limited. Speech may also be affected, especially if there is difficulty moving the lower jaw, articulation is impaired.
• Nerve damage. If the tumor presses on or infiltrates the inferior alveolar nerve, permanent numbness, loss of sensation, or pain may develop. There is also a risk of nerve damage during surgery. Loss of sensation in the lip, chin, teeth, or tongue affects quality of life.
• Airway obstruction. Very large upper jaw ameloblastomas can obstruct the nasal cavity, sinuses, or nasopharynx. This can lead to breathing difficulty. Rare but can be life-threatening.
• Eye problems. Advanced ameloblastoma in the upper jaw can extend to the eye socket (orbit). This causes restriction in eye movements, double vision, eye protrusion (proptosis), or vision loss. Emergency surgical intervention is required.
• Infection. The tumor can lead to dental infections or abscess formation. If oral hygiene is poor or the tumor opens into the oral cavity, chronic infection develops. In rare cases, osteomyelitis (bone infection) may occur.
• Malignant transformation. In very rare cases, ameloblastoma can transform into malignancy (cancer) (ameloblastic carcinoma). This is usually seen in recurrent ameloblastoma or after radiotherapy. Malignant transformation increases the risk of metastasis.
• Recurrence. The most important complication of ameloblastoma is high recurrence rate. Conventional ameloblastoma can recur in 50-90% of cases after conservative treatment. Even after aggressive surgery, there is a 10-20% recurrence risk. Recurrence can occur even years later, so long-term follow-up is essential.
• Surgical complications. Ameloblastoma surgery may require major reconstruction. Complications include bleeding, infection, nerve damage, jaw fracture, scar formation, and aesthetic problems. Bone grafts or implants may be needed.

Diagnosis of Ameloblastoma

Ameloblastoma is diagnosed through clinical examination, imaging methods, and biopsy. Early diagnosis increases treatment success and reduces complications.

Your doctor first asks about your medical and dental history. Questions include when your symptoms started, the growth rate of swelling, pain, or dental problems. Your jaw and face are carefully examined. The size, location, and firmness of swelling are evaluated. Teeth and gums are checked. Lymph nodes are palpated for enlargement.

Imaging Tests

• Panoramic dental X-ray. Initial imaging is usually done with panoramic X-ray (orthopantomogram). This shows the entire jawbone and teeth in a single image. Ameloblastoma typically appears as a multilocular (multi-compartmented) radiolucent (radiotranslucent, dark) area with a "soap bubble" or "honeycomb" appearance. Unicystic ameloblastoma appears as a single radiolucent cyst.
• Computed tomography (CT). CT scan is the gold standard for evaluating the size, location, and degree of bone destruction of the tumor. Three-dimensional reconstruction is helpful in surgical planning. CT shows whether the tumor has invaded surrounding structures (sinuses, orbit, nerves). Contrast medium may be used.
• Magnetic resonance imaging (MRI). MRI better shows soft tissue details. It is useful in evaluating the content of the tumor (solid, cystic), soft tissue involvement, and nerve infiltration. It is used in combination with CT.
• Cone beam CT (CBCT). CBCT, used in dentistry, provides high-resolution dental and jaw images. It shows tooth-related lesions in detail and the radiation dose is lower than conventional CT.

Biopsy and Histopathological Examination

Definitive diagnosis is made by biopsy. Fine needle aspiration biopsy (FNAB) is not reliable in ameloblastoma diagnosis because cellular detail is insufficient. Incisional biopsy (taking a portion of the tumor) or excisional biopsy (complete removal and examination of the tumor) is preferred.

The biopsy specimen is examined under a microscope by a pathologist. Ameloblastoma shows characteristic histopathological features: peripheral cells in palisading arrangement, central cells resembling stellate reticulum, follicular or plexiform pattern. The pathology report determines the type of ameloblastoma (conventional, unicystic, desmoplastic) and subtype.

• Molecular tests. In some centers, BRAF mutation testing may be performed. The BRAF V600E mutation is found in some ameloblastomas and may be a potential target for targeted therapy (BRAF inhibitors) (experimental).

Treatment of Ameloblastoma

Treatment of ameloblastoma is primarily surgical. The treatment approach is determined according to the tumor's type, size, location, and patient's age.

Surgical Treatment

Surgery is the main option in ameloblastoma treatment. Surgical approaches are divided into two categories: conservative (tissue-preserving) treatment and radical (aggressive) treatment.

• Conservative treatment (Enucleation and curettage). In this method, the tumor is carefully peeled away (enucleation) and the bone surface is scraped (curettage). Sometimes the edges of the tumor cavity are drilled with a burr or cryotherapy (freezing) is applied. Conservative treatment is less invasive, more bone and teeth are preserved, functional and aesthetic results are better. However, recurrence risk is high (50-90%). Conservative treatment is generally preferred for unicystic ameloblastoma or very young patients.
• Radical treatment (Resection). In this method, the tumor is widely removed along with surrounding healthy bone (en bloc resection). The safe surgical margin is generally 1-2 cm beyond the visible tumor boundary. Radical resection significantly reduces recurrence risk (5-15%). However, it leads to greater bone and tooth loss and requires reconstruction. It is the standard treatment for conventional (solid/multicystic) ameloblastoma.
• Segmental resection. This is complete removal of a section of the lower jaw. It is necessary if the tumor is large or has severely affected the jawbone. After resection, the jaw is reconstructed with bone grafts (fibula, iliac crest), titanium reconstruction plates, or microvascular free flap.
• Maxillectomy. For ameloblastoma in the upper jaw, this is removal of part or all of the upper jaw. Upper jaw resection is more complex because of proximity to nasal, sinus, and eye structures. Reconstruction is done with obturator prosthesis (closure plate) or microsurgical flap.
• Marginal resection. This is removal of only a portion (margin) of the jawbone, jaw continuity is preserved. It can be applied for smaller tumors or if the tumor involves only one surface of the jawbone. It is less invasive than segmental resection.

Reconstruction

Jaw reconstruction is usually necessary after ameloblastoma surgery. Reconstruction methods include:

• Bone grafts. The patient's own bone (autograft) is taken from another site (fibula, iliac bone, scapula) and placed in the jaw defect. Fibula free flap (leg bone transferred with vascular network) is the gold standard in jaw reconstruction. The graft integrates over time and dental implants can be placed.
• Titanium reconstruction plates. In large bone losses, titanium plates are used to maintain jaw continuity. Plates can be used in combination with bone grafts or alone.
• Obturator prosthesis. For upper jaw defects, this is a closure plate specially made by a prosthetist. It separates the oral cavity from the nasal cavity, improving speech and swallowing function.
• Dental implants and prostheses. After reconstruction has healed (usually 6-12 months later), dental implants can be placed and prosthetic teeth attached. This restores chewing function and aesthetics.

Radiotherapy and Chemotherapy

• Radiotherapy. Ameloblastoma is generally resistant to radiotherapy. Radiotherapy is not routinely used for ameloblastoma. However, in very advanced cases that cannot be operated, in patients who have recurred and cannot be reoperated, or in malignant ameloblastoma (ameloblastic carcinoma), palliative radiotherapy may be considered. Side effects of radiotherapy (jaw bone necrosis, tooth loss) are significant.
• Chemotherapy. Chemotherapy is not effective in standard ameloblastoma treatment. In very rare cases such as metastatic ameloblastic carcinoma, chemotherapy may be tried but success is limited.
• Targeted therapies (Experimental). In BRAF mutation-positive ameloblastomas, BRAF inhibitors (vemurafenib, dabrafenib) have been used experimentally. In some cases, tumor shrinkage has been achieved. However, these treatments are not yet standard and clinical trials are ongoing. Hedgehog pathway inhibitors are also being investigated.

Post-Treatment and Follow-up

Regular and long-term follow-up is critically important after ameloblastoma treatment. Lifelong monitoring may be necessary due to recurrence risk.

• Healing process. Swelling, pain, and difficulty eating and drinking are normal in the first weeks after surgery. Pain relievers and antibiotics are prescribed. A soft food diet is recommended. Oral hygiene is very important; gentle brushing and mouth rinses prevent infection. Stitches are usually removed after 10-14 days. Complete healing may take 6-12 weeks.
• Functional rehabilitation. Jaw movement exercises help prevent trismus (difficulty opening mouth). Physical therapy is recommended. Speech therapy can correct speech problems. A nutritionist can help ensure adequate calorie and nutrient intake.
• Follow-up schedule. Check-ups every 3 months in the first year are recommended. Every 4-6 months in the second and third years. Thereafter, annual check-ups may be sufficient. However, because recurrence risk continues, some experts recommend lifelong annual follow-up. Follow-up includes clinical examination, panoramic X-ray, CT, or MRI.
• Recurrence detection. Recurrence usually occurs within the first 5 years but can be seen even 10-20 years later. Early intervention in recurrence detection is important. If new swelling, pain, or dental problems develop, inform your doctor immediately. In recurrence cases, reoperation may be necessary and treatment may be more difficult.
• Psychological support. Ameloblastoma treatment can lead to aesthetic and functional changes. Facial deformity, tooth loss, and speech problems can create psychological stress. Psychological support, support groups, and counseling can improve quality of life.
• Quality of life. Most patients return to normal life after treatment. Reconstruction and prostheses can largely restore function and appearance. However, there may be some permanent effects: facial asymmetry, chewing restrictions, speech changes. These problems are minimized with adaptation and rehabilitation.

Preparing for Your Appointment

When seeing a dentist or oral surgeon with jaw swelling or suspected ameloblastoma, being prepared facilitates the diagnosis and treatment process.

What you can do:

• Note your symptoms (When did swelling start? Is it growing? Is there pain?).
• Prepare your dental history (impacted teeth, dental cysts, past dental treatments).
• Bring previous dental X-rays.
• List medications you use (prescription, over-the-counter).
• Mention if there are tumors or dental problems in your family.
• Take photos of symptoms (to show growth of swelling).
• Write your questions in advance.
• If possible, bring a companion.

Questions you can ask your doctor:

• Is this ameloblastoma? What type?
• What is the size and extent of the tumor?
• What are the treatment options?
• Which surgical approach do you recommend?
• Will reconstruction be necessary?
• What is the recurrence risk?
• How long is the recovery time?
• Will my chewing and speech functions be affected?
• How often is follow-up needed?
• Is there a risk of malignancy?

Your doctor may ask you:

• When did the swelling start?
• Is it growing rapidly?
• Is there pain?
• Have you noticed loosening or shifting of your teeth?
• Are you experiencing difficulty chewing or opening your mouth?
• Is there numbness in your face?
• Have you had a dental cyst or tumor before?
• Are there similar problems in the family?
• Do you smoke or use alcohol?